TY - JOUR
T1 - Business travel-associated illness
T2 - A GeoSentinel analysis
AU - For the GeoSentinel Surveillance Network
AU - Chen, Lin H.
AU - Leder, Karin
AU - Barbre, Kira A.
AU - Schlagenhauf, Patricia
AU - Libman, Michael
AU - Keystone, Jay
AU - Mendelson, Marc
AU - Gautret, Philippe
AU - Schwartz, Eli
AU - Shaw, Marc
AU - MacDonald, Sue
AU - McCarthy, Anne
AU - Connor, Bradley A.
AU - Esposito, Douglas H.
AU - Hamer, Davidson
AU - Wilson, Mary E.
AU - von Sonnenburg, Frank
AU - Rothe, Camilla
AU - Kain, Kevin
AU - Boggild, Andrea
AU - Cramer, Jakob
AU - Jordan, Sabine
AU - Vinnemeier, Christof
AU - Yansouni, Cedric
AU - Chappuis, Francois
AU - Caumes, Eric
AU - Perignon, Alice
AU - Torresi, Joe
AU - Kanagawa, Shuzo
AU - Kato, Yasuyuki
AU - Grobusch, Martin
AU - Goorhuis, Bram
AU - Javelle, Emilie
AU - Kozarsky, Phyllis
AU - Wu, Henry
AU - Yoshimura, Yukiriro
AU - Tachikawa, Natsuo
AU - Lim, Poh Lian
AU - Piyaphanee, Watcharapong
AU - Silachamroon, Udomsak
AU - Murphy, Holly
AU - Pandey, Prativa
AU - Ásgeirsson, Hilmir
AU - Glans, Hedvig
AU - Jensenius, Mogens
AU - Borwein, Sarah
AU - Hale, Devon
AU - Leung, Daniel
AU - Benson, Scott
AU - Cahill, John
N1 - Funding Information:
GeoSentinel, the global surveillance network of the International Society of Travel Medicine (ISTM), is supported by a cooperative agreement (U50CK00189) from the Centers for Disease Control and Prevention, International Society of Travel Medicine, and Public Health Agency of Canada. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the CDC.
Publisher Copyright:
© International Society of Travel Medicine, 2017. Published by Oxford University Press. All rights reserved.
PY - 2018/2/1
Y1 - 2018/2/1
N2 - Background: Analysis of a large cohort of business travelers will help clinicians focus on frequent and serious illnesses. We aimed to describe travel-related health problems in business travelers. Methods: GeoSentinel Surveillance Network consists of 64 travel and tropical medicine clinics in 29 countries; descriptive analysis was performed on ill business travelers, defined as persons traveling for work, evaluated after international travel 1 January 1997 through 31 December 2014. Results: Among 12 203 business travelers seen 1997-2014 (14 045 eligible diagnoses), the majority (97%) were adults aged 20-64 years; most (74%) reported from Western Europe or North America; two-thirds were male. Most (86%) were outpatients. Fewer than half (45%) reported a pre-travel healthcare encounter. Frequent regions of exposure were sub-Saharan Africa (37%), Southeast Asia (15%) and South Central Asia (14%). The most frequent diagnoses were malaria (9%), acute unspecified diarrhea (8%), viral syndrome (6%), acute bacterial diarrhea (5%) and chronic diarrhea (4%). Species was reported for 973 (90%) of 1079 patients with malaria, predominantly Plasmodium falciparum acquired in sub-Saharan Africa. Of 584 (54%) with malaria chemoprophylaxis information, 92% took none or incomplete courses. Thirteen deaths were reported, over half of which were due to malaria; others succumbed to pneumonia, typhoid fever, rabies, melioidosis and pyogenic abscess. Conclusions: Diarrheal illness was a major cause of morbidity. Malaria contributed substantial morbidity and mortality, particularly among business travelers to sub-Saharan Africa. Underuse or non-use of chemoprophylaxis contributed to malaria cases. Deaths in business travelers could be reduced by improving adherence to malaria chemoprophylaxis and targeted vaccination for vaccine-preventable diseases. Pre-travel advice is indicated for business travelers and is currently under-utilized and needs improvement.
AB - Background: Analysis of a large cohort of business travelers will help clinicians focus on frequent and serious illnesses. We aimed to describe travel-related health problems in business travelers. Methods: GeoSentinel Surveillance Network consists of 64 travel and tropical medicine clinics in 29 countries; descriptive analysis was performed on ill business travelers, defined as persons traveling for work, evaluated after international travel 1 January 1997 through 31 December 2014. Results: Among 12 203 business travelers seen 1997-2014 (14 045 eligible diagnoses), the majority (97%) were adults aged 20-64 years; most (74%) reported from Western Europe or North America; two-thirds were male. Most (86%) were outpatients. Fewer than half (45%) reported a pre-travel healthcare encounter. Frequent regions of exposure were sub-Saharan Africa (37%), Southeast Asia (15%) and South Central Asia (14%). The most frequent diagnoses were malaria (9%), acute unspecified diarrhea (8%), viral syndrome (6%), acute bacterial diarrhea (5%) and chronic diarrhea (4%). Species was reported for 973 (90%) of 1079 patients with malaria, predominantly Plasmodium falciparum acquired in sub-Saharan Africa. Of 584 (54%) with malaria chemoprophylaxis information, 92% took none or incomplete courses. Thirteen deaths were reported, over half of which were due to malaria; others succumbed to pneumonia, typhoid fever, rabies, melioidosis and pyogenic abscess. Conclusions: Diarrheal illness was a major cause of morbidity. Malaria contributed substantial morbidity and mortality, particularly among business travelers to sub-Saharan Africa. Underuse or non-use of chemoprophylaxis contributed to malaria cases. Deaths in business travelers could be reduced by improving adherence to malaria chemoprophylaxis and targeted vaccination for vaccine-preventable diseases. Pre-travel advice is indicated for business travelers and is currently under-utilized and needs improvement.
KW - Business
KW - Death
KW - Diarrhea
KW - Malaria
KW - Occupational medicine
KW - Travel
KW - Vaccine-preventable disease
UR - http://www.scopus.com/inward/record.url?scp=85042648590&partnerID=8YFLogxK
U2 - 10.1093/jtm/tax097
DO - 10.1093/jtm/tax097
M3 - Article
C2 - 29462444
AN - SCOPUS:85042648590
SN - 1195-1982
VL - 25
JO - Journal of Travel Medicine
JF - Journal of Travel Medicine
IS - 1
M1 - tax097
ER -